Skip to main content
. 2014 Jan 24;9(1):e85592. doi: 10.1371/journal.pone.0085592

Figure 3. Kaplan-Meier survival analysis of PTPN12 expression in patients with HCC (log-rank test).

Figure 3

A. The PTPN12 expression and the probability of cancer-specific survival of all patients with HCC: decreased expression, n = 147, normal expression, n = 101. B. Probability of cancer-specific survival of the PTPN12 expression in HCC patients at stage I-II: l decreased expression, n = 99, normal expression, n = 74. C. Probability of cancer-specific survival of the PTPN12 expression in HCC patients at stage III-IV: decreased expression, n = 48, normal expression, n = 27. D. The PTPN12 expression and the probability of recurrence-free survival of all patients with HCC: decreased expression, n = 147, normal expression, n = 101. E. Probability of recurrence-free survival of the PTPN12 expression in HCC patients at stage I-II: l decreased expression, n = 99, normal expression, n = 74. F. Probability of recurrence-free survival of the PTPN12 expression in HCC patients at stage III-IV: decreased expression, n = 48, normal expression, n  = 27.